Drug Metabolism and Pharmacokinetics

Titel Veröffentlichungsdatum Sprache Zitate
Prediction of Therapeutic Doses of Antipsychotic Drugs as Dopamine D2 Receptor Antagonists. Approach Based on Receptor Occupancy Theory.1993/01/01English3
Studies on the Metabolic Fate of L-Carnosine in Rats and Humans.1993/01/01English3
Pharmacokinetics of Salazosulfapyridine (Sulfasalazine, SASP). (I). Plasma kinetics and plasma metabolites in the rat after a single intravenous or oral administration.1991/01/01English3
Effect of Biliary Excretion on the Pharmacokinetics of Pitavastatin (NK-104) in Dogs.2001/01/01English3
Metabolic Fate of 4-amino-1-hydroxybutylidene-1,1-bisphosphonate(alendronate). (II). Plasma Concentration, Distribution and Excretion after Repeated Intravenous Administration to 7-week Old Rats and after Single Intravenous Administration to 30-week Old Rats, and Transfer into the Fetus and Milk in Rats.1995/01/01English3
Oxidative Metabolism of Tacrolimus and its Metabolite by Human Cytochrome P450 3A Subfamily.1999/01/01English3
The Study on CYP2D6*10 In Vivo and In Vitro.2000/01/01English3
Pharmacokinetic studies of 1.ALPHA., 24(R)-(OH)2D3(TV-02)(2). Plasma level, distribution, metabolism and excretion after repeated subcutaneous administration to rats.1990/01/01English3
Metabolic Fate of Menaquinone-4 in Dogs. (I). Absorption, Distribution, Metabolism and Excretion after a Single Oral Administration.1997/01/01English2
Absorption, distribution and excretion of 1-(bis(4-fluorophenyl)methyl)-4-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride (KB-2796) after single oral administration in rats.1990/01/01English2
A Topological Analysis of the Drug Binding Sites on Human Serum Albumin.2001/01/01English2
Pharmacokinetics of OPB-2045 in Rats: Systemic Exposure following Oral, Subcutaneous, and Intravenous Administration.1998/01/01English2
Intestinal absorption and tissue distribution of immunoactive and antiviral water-soluble (14C) lignins in rats.1990/01/01English2
Studies on the Metabolic Fate of Leukotriene Antagonist ONO-1078. (1). Absorption, Distribution and Excretion after Single Administration to Rats.1993/01/01English2
Enantioselective disposition of loxoprofen in the rat and man.1990/01/01English2
Disposition of Taltirelin. (1): Absorption, Distribution, Metabolism and Excretion in Rats and Dogs.1997/01/01English2
Stereoselective Metabolism Studies on Loxoprofen, a 2-Arylpropionic Acid Nonsteroidal Anti-inflammatory Drug, and Its Role for the Development as a Prodrug.1993/01/01English2
Enhancement of antitumor activity of carmofur (HCFU) by dimethyl-.BETA.-cyclodextrin complexation in P-388 leukemia-bering mice.1988/01/01English2
Validation Studies of Radioluminography. I. Measurement of Background Value.1998/01/01English2
Pharmacokinetics of Salazosulfapyridine (Sulfasalazine, SASP). V. Pharmacokinetics of SASP after a single intravenous or oral administration in the dog.1991/01/01English2
Studies on the Metabolic Fate of Miconazole. (3). The Absorption, Distribution and Metabolism after Application of Miconazole to Oral Mucosa of Rats.1993/01/01English2
Pharmacokinetic/Pharmacodynamic Evaluation of the Risk of Adverse Reaction on Central Nervous System Induced by H2 receptor antagonists. Hepatic and/or Renal Disease as Risk Factors.1993/01/01English2
Studies on the Metabolic Fate of Leukotriene Antagonist ONO-1078. (4). Metabolism and Protein Binding.1993/01/01English2
Pharmacokinetics of Sotalol Enantiomers after Single and Repeated Oral Administration of Sotalol Hydrochloride to Rats.1995/01/01English2
Oxidative Stress Produced by Drugs and Chemicals and the Induction of Heme Oxygenase.1997/01/01English2
Metabolic Fate of Losartan, a New Angiotensin II Receptor Antagonist. (2). Absorption, Distribution, Metabolism, Excretion and Effects on Drug Metabolizing Enzyme Activities after Repeated Oral Administration in Rats.1995/01/01English2
Pharmacokinetics and biotransformation of beraprost sodium. IV. Metabolism of beraprost sodium in rat.1989/01/01English2
Pharmacokinetics and biotransformation of beraprost sodium. VI. Metabolism and excretion of beraprost sodium in dog.1989/01/01English2
Induction and Inhibition of Intestinal P-glycoprotein and Effects on Etoposide Absorption1993/01/01English2
Absorption, Distribution, Excretion, and Sex Differences in the Disposition of the Antiosteolytic Agent, Alendronate after Oral Administration in Rats.1998/01/01English2